CORC  > 中国医学科学院 北京协和医学院
Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis
Wang, Liming; Chen, Bo; Li, Zhuo; Yao, Xuesong; Liu, Mei; Rong, Weiqi; Wu, Fan; Lin, Shengtao; Liu, Yunhe; Zheng, Yiling
2019
卷号12页码:1237-1247
关键词hepatocellular carcinoma microvascular invasion radiotherapy TACE relapse-free survival
ISSN号1178-6930
DOI10.2147/OTT.S179247
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6344467
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Wang, Liming,Chen, Bo,Li, Zhuo,et al. Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis[J],2019,12:1237-1247.
APA Wang, Liming.,Chen, Bo.,Li, Zhuo.,Yao, Xuesong.,Liu, Mei.,...&Wu, Jianxiong.(2019).Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis.,12,1237-1247.
MLA Wang, Liming,et al."Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis".12(2019):1237-1247.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace